Abstract | OBJECTIVES: STUDY DESIGN: Case series with planned data collection. SETTING: Yamagata University School of Medicine. SUBJECTS AND METHODS: We tried this therapy in 21 patients with auricular hematoma between January 2001 and February 2009. We injected OK-432 solution into the lesion with a 27-gauge needle to prevent the leak of the agent out of the hematoma. We performed this treatment on an outpatient basis without hospitalization. RESULTS: Disappearance or marked reduction of the lesion were observed in all patients who had this therapy, and local scarring and deformity of the auricle did not occur in any patients. As for side effects, local pain at the injection site and fever (37 degrees C-38 degrees C) were observed in a few of the patients who had this therapy, but such problems resolved within a few days. CONCLUSION:
|
Authors | Toshinori Kubota, Nobuo Ohta, Shigeru Fukase, Yoshihisa Kon, Masaru Aoyagi |
Journal | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
(Otolaryngol Head Neck Surg)
Vol. 142
Issue 6
Pg. 863-6
(Jun 2010)
ISSN: 1097-6817 [Electronic] England |
PMID | 20493359
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Picibanil
|
Topics |
- Adolescent
- Adult
- Aged
- Antineoplastic Agents
(administration & dosage, therapeutic use)
- Ear Auricle
- Ear Diseases
(drug therapy)
- Female
- Hematoma
(drug therapy)
- Humans
- Injections, Intralesional
- Male
- Middle Aged
- Picibanil
(administration & dosage, therapeutic use)
- Prospective Studies
- Treatment Outcome
- Young Adult
|